8 aa
Predicted · Cα pLDDT 97.5 / 100
Completion observed (Asia/Shanghai):
Static model
PAE · Å
PAE image is unavailable.
pTM 0.03
A few molecular notes beside a poem.
TRYAGAIN
These model readings are not real-world event rates; suitability for this peptide has not been validated.
Modelled molecular behavior
Each endpoint keeps its own 0–1 model output; these are not cross-endpoint rankings.
Absorption & transport
- Intestinal absorption · HIA
- 0.03
- Oral bioavailability
- 0.31
- Blood–brain barrier · BBB
- 0.08
- P-gp
- 0.28
Metabolism · CYP
Safety-related assays
- Ames assay
- 0.12
- Drug-induced liver injury · DILI
- 0.33
- hERG channel
- 0.59
Reading notes & six additional results
Classification outputs are uncalibrated; they do not establish individual event probabilities or safety.
Method: TabPFN2.5 · tdc22_v1
Chemical form: linear L-peptide, with free, neutral termini and side chains.
Units and numerical scales for these six endpoints remain unconfirmed; the model readings are retained below.
- Caco-2
- -7.39
- Hepatocyte clearance
- 10.62
- Microsomal clearance
- 49.20
- Half-life
- 4.44
- Plasma protein binding
- 52.60
- Distribution volume
- 0.28
Readings retain the scale returned for each endpoint; no conversion to linear physical quantities has been made. Glyphs identify endpoints, not measurement axes.